Ed Shovelin: Pplus Medical Limited Will Be Giving Demos of the Platelet DSD at ICTHIC 2026
Ed Shovelin, Operations and Engineering Manager at Pplus Medical Limited, reposted from Pplus Medical Limited on LinkedIn:
“Pplus Medical Limited will be giving demos of the Platelet Digital Storage Device (DSD) and info on our in demand Synthethic Platelet Agonist CRP-A at the ICTHIC – International Conference on Thrombosis and Hemostasis Issues in Cancer in Bergoma, Italy April 17th-19th 2026.
Visit our booth if attending the conference.”
Quoting Pplus Medical Limited‘s post:
“ICTHIC – International Conference on Thrombosis and Hemostasis Issues in Cancer
Pplus Medical Limited is pleased to be attending this year’s meeting in Bergamo, Italy, taking place 17–19 April.
This important event brings together leading clinicians, researchers, and innovators working at the intersection of cancer and coagulation—areas in which our pioneering products have become valuable tools supporting life‑saving research and clinical progress.
If you’ll be there, feel free to reach out. We would welcome the opportunity to connect, discuss our latest developments, and share more about our platelet‑focused products and technologies.
Looking forward to productive conversations and to meeting both new and familiar faces in Bergamo.”
Stay updated on all scientific advances with Hemostasis Today.
-
May 24, 2026, 13:46Sergio Emanuel Kaiser: A Whole New Array of Potent Oral PCSK9 Inhibitors
-
May 24, 2026, 13:10Thomas Pincez: Emerging Challenges in Sickle Cell Disease Gene Therapy and Cancer Risk
-
May 24, 2026, 12:04Kalpana Gupta Shekhawat: Ferritin Is More Than an Iron Marker
-
May 24, 2026, 11:50Peter Zdziarski: Making Rare Disease Research More Human
-
May 24, 2026, 11:39Bram Berkelmans: Donating with a View
-
May 24, 2026, 11:28Ratiporn Chinthammit: A Meaningful Exchange in aHUS and PNH Education
-
May 24, 2026, 11:17Mary Ann Sromoski: Transfusion Medicine and Patient Blood Management in Practice
-
May 24, 2026, 07:45Thierry Burnouf: Advances in Platelet Membrane-Coated Nanoparticles for Targeted Therapeutics and Regenerative Medicine
-
May 24, 2026, 07:39Shamala Thilarajah: Our Team Receives the NMRC Transition Award for NEUROACT-Stroke